These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 1354573

  • 1. Octreotide decreased liver metabolic activity in patients with hepatitis B surface antigen-positive cirrhosis.
    Lin HC, Tsai YT, Lee SD, Lee FY, Hsia HC, Meng HC, Wang SS, Lo KJ.
    Clin Pharmacol Ther; 1992 Aug; 52(2):134-8. PubMed ID: 1354573
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis.
    Lin HC, Tsai YT, Lee FY, Lee SD, Hsia HC, Lin WJ, Lo KJ.
    Gastroenterology; 1992 Jul; 103(1):229-34. PubMed ID: 1612330
    [Abstract] [Full Text] [Related]

  • 3. Effects of octreotide on postprandial systemic and hepatic hemodynamics in patients with postnecrotic cirrhosis.
    Lin HC, Tsai YT, Huang CC, Meng HC, Lee FY, Wang SS, Lee SD, Lo KJ.
    J Hepatol; 1994 Sep; 21(3):424-9. PubMed ID: 7836713
    [Abstract] [Full Text] [Related]

  • 4. The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients.
    Ottesen LH, Flyvbjerg A, Møller S, Bendtsen F.
    Aliment Pharmacol Ther; 1998 Jul; 12(7):657-65. PubMed ID: 9701530
    [Abstract] [Full Text] [Related]

  • 5. Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO-independent mechanism in chronic liver disease.
    Matrella E, Valatas V, Notas G, Roumpaki H, Xidakis C, Hadzidakis A, Mouzas I, Kouroumalis E.
    Aliment Pharmacol Ther; 2001 Jun; 15(6):857-64. PubMed ID: 11380324
    [Abstract] [Full Text] [Related]

  • 6. The influence of vasoactive agents on metabolic activity of the liver in cirrhosis: a study of the effects of posterior pituitary extract, vasopressin, and somatostatin.
    Barbare JC, Poupon R, Jaillon P, Bories P, Aussanaire M, Darnis F, Michel H, Cheymol G.
    Hepatology; 1984 Jun; 4(1):59-62. PubMed ID: 6141135
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure.
    Jenkins SA, Nott DM, Baxter JN.
    HPB Surg; 1998 Jun; 11(1):13-21. PubMed ID: 9830576
    [Abstract] [Full Text] [Related]

  • 8. The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites.
    Lay CS, Tsai YT, Kong CW, Lee FY, Chang TT, Lin HC, Yang CM, Lee SD, Chiang BN, Lo KJ.
    Clin Pharmacol Ther; 1988 Oct; 44(4):453-7. PubMed ID: 3168396
    [Abstract] [Full Text] [Related]

  • 9. Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man.
    Jenkins SA, Baxter JN, Corbett WA, Shields R.
    Br J Surg; 1985 Dec; 72(12):1009-12. PubMed ID: 2867802
    [Abstract] [Full Text] [Related]

  • 10. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
    Baik SK, Jeong PH, Ji SW, Yoo BS, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW, Chang SJ, Lee SS.
    Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
    [Abstract] [Full Text] [Related]

  • 11. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis.
    Hsia HC, Lin HC, Lee FY, Tsai YT, Lee SD, Meng HC, Chao Y, Wang SS, Lo KJ.
    J Gastroenterol Hepatol; 1993 Mar; 8(1):15-20. PubMed ID: 8094983
    [Abstract] [Full Text] [Related]

  • 12. Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy.
    Vanheule E, Geerts AM, Reynaert H, Van Vlierberghe H, Geerts A, De Vos M, Colle I.
    Liver Int; 2008 Jan; 28(1):107-16. PubMed ID: 18173562
    [Abstract] [Full Text] [Related]

  • 13. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
    Cirera I, Feu F, Luca A, García-Pagán JC, Fernández M, Escorsell A, Bosch J, Rodés J.
    Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
    [Abstract] [Full Text] [Related]

  • 14. The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis.
    Wahren J, Eriksson LS.
    Scand J Gastroenterol Suppl; 1986 Jul; 119():103-8. PubMed ID: 2876492
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis.
    Eriksson LS, Brundin T, Söderlund C, Wahren J.
    Scand J Gastroenterol; 1987 Oct; 22(8):919-25. PubMed ID: 2891184
    [Abstract] [Full Text] [Related]

  • 17. The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the cirrhotic rat.
    Jenkins SA, Baxter JN, Corbett WA, Shields R.
    Br J Surg; 1985 Nov; 72(11):864-7. PubMed ID: 2866012
    [Abstract] [Full Text] [Related]

  • 18. Effect of octreotide on total effective vascular compliance in patients with posthepatitic cirrhosis.
    Lin HC, Tsai YT, Yang MC, Lee FY, Hou MC, Chen LS, Lee SD.
    J Hepatol; 1996 Jan; 24(1):81-7. PubMed ID: 8834029
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular effects of octreotide in patients with hepatic cirrhosis.
    McCormick PA, Chin J, Greenslade L, Karatapanis S, Dick R, McIntyre N, Burroughs AK.
    Hepatology; 1995 May; 21(5):1255-60. PubMed ID: 7737631
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.